XBIT vs. XBI
Compare and contrast key facts about XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Performance
XBIT vs. XBI - Performance Comparison
Loading graphics...
XBIT vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBIT XBiotech Inc. | -2.09% | -39.49% | -1.25% | 13.96% | -68.46% | -17.46% | -16.15% | 267.42% | 28.93% | -61.07% |
XBI SPDR S&P Biotech ETF | 5.43% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Returns By Period
In the year-to-date period, XBIT achieves a -2.09% return, which is significantly lower than XBI's 5.43% return. Over the past 10 years, XBIT has underperformed XBI with an annualized return of -11.73%, while XBI has yielded a comparatively higher 9.39% annualized return.
XBIT
- 1D
- -0.43%
- 1M
- 0.86%
- YTD
- -2.09%
- 6M
- -11.36%
- 1Y
- -22.52%
- 3Y*
- -12.14%
- 5Y*
- -30.80%
- 10Y*
- -11.73%
XBI
- 1D
- 0.64%
- 1M
- 1.58%
- YTD
- 5.43%
- 6M
- 27.21%
- 1Y
- 65.07%
- 3Y*
- 19.25%
- 5Y*
- -1.16%
- 10Y*
- 9.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBIT vs. XBI — Risk / Return Rank
XBIT
XBI
XBIT vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XBIT | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.38 | 2.28 | -2.66 |
Sortino ratioReturn per unit of downside risk | -0.22 | 2.99 | -3.21 |
Omega ratioGain probability vs. loss probability | 0.98 | 1.38 | -0.40 |
Calmar ratioReturn relative to maximum drawdown | -0.70 | 4.41 | -5.12 |
Martin ratioReturn relative to average drawdown | -1.17 | 16.21 | -17.37 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XBIT | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.38 | 2.28 | -2.66 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | -0.04 | -0.45 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.15 | 0.29 | -0.45 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | 0.36 | -0.59 |
Correlation
The correlation between XBIT and XBI is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
XBIT vs. XBI - Dividend Comparison
XBIT has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.34%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBIT XBiotech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Drawdowns
XBIT vs. XBI - Drawdown Comparison
The maximum XBIT drawdown since its inception was -92.67%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for XBIT and XBI.
Loading graphics...
Drawdown Indicators
| XBIT | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.67% | -63.89% | -28.78% |
Max Drawdown (1Y)Largest decline over 1 year | -39.43% | -13.39% | -26.04% |
Max Drawdown (5Y)Largest decline over 5 years | -87.21% | -55.04% | -32.17% |
Max Drawdown (10Y)Largest decline over 10 years | -90.72% | -63.89% | -26.83% |
Current DrawdownCurrent decline from peak | -91.38% | -25.70% | -65.68% |
Average DrawdownAverage peak-to-trough decline | -69.78% | -20.91% | -48.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.84% | 3.65% | +20.19% |
Volatility
XBIT vs. XBI - Volatility Comparison
The current volatility for XBiotech Inc. (XBIT) is 7.77%, while SPDR S&P Biotech ETF (XBI) has a volatility of 11.31%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XBIT | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.77% | 11.31% | -3.54% |
Volatility (6M)Calculated over the trailing 6-month period | 40.36% | 19.25% | +21.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.87% | 28.95% | +30.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.08% | 32.23% | +31.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.92% | 32.15% | +43.77% |